Overview :: Rezolute, Inc. (RZLT)

Investor Relations Overview

Rezolute is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases.

Corporate Presentation

Stock Snapshot

RZLT Symbol

OTCQB Market

Price

Change

Volume

View Detailed Stock Data

Recent News

Aug 5, 2019 Rezolute Management to Present at 2019 Canaccord Genuity Growth Conference
Jul 24, 2019 Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option
Jan 7, 2019 Rezolute Announces $25 Million Private Placement -- Potential Total Investment of $45 Million

View Press Releases

AntriaBio

Investors

Overview

Investor Relations Overview

Corporate Presentation

Stock Snapshot

Recent News